Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type Clinical Trial
Official title:
Radiotherapy With Inductive and Concurrent Anti-PD-1 Antibody in Early-stage Low-risk Extranodal NK/T Cell Lymphoma, Nasal Type: A Multi-center Phase II Study
The current study is a phase II multi-center single arm trial to evaluate the efficacy and safety of adding Anti-PD-1 antibody in an inductive and concurrent way to radiotherapy in early-stage low-risk extranodal NK/T cell lymphoma, nasal type
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05254899 -
Anti-PD-1 Antibody and P-GEMOX Chemotherapy Combined With Radiotherapy in High-risk Early-Stage ENKTL
|
Phase 2 | |
| Completed |
NCT01238159 -
Concomitant Chemo-radiotherapy Followed by MIDLE Chemotherapy in Stage I/II Extranodal NK/T-cell Lymphoma
|
Phase 2 | |
| Recruiting |
NCT02085655 -
PEG-ASP+Gemox Regimen and Thalidomide for NK/T Lymphoma
|
Phase 3 |